Features
Choosing Treatment for Primary Vitreoretinal Lymphoma
Weigh benefits and drawbacks of different modalities before making a selection.
By Elaine Binkley, MD, Farzad Jamshidi, MD, PhD
Intravitreal Chemotherapy for Retinoblastoma
A safe and effective treatment for vitreous seeds.
By Vishal R. Raval, MD, Vidhi Bajpai, MS, Arun D. Singh, MD
Current Trials in Uveal Melanoma
Three promising treatments are being tested to prevent or mitigate the effects of radiation.
By Yehonatan Weinberger, MD, Arun D. Singh, MD
New Drug Therapies for Benign Retinal Tumors
mTOR inhibitors and HIF-2α inhibitors have emerged as potential options.
By Mary E. Aronow, MD
Web Exclusives
The Role of TNF-α Inhibitors in Managing Wet AMD
Current literature does not support their use, but newer agents deserve further investigation.
By Christian Akotoye, MD, Priya Shukla, BS, Rishi P. Singh, MD
Retinal Toxicity of Immunotherapy Drugs
Related retinopathy often can be managed successfully with steroids.
By William Wagner, MD, Saam Mojtahed, MD, Arun D. Singh, MD
Departments
Upfront: How Far We've Come
A broad variety of new therapeutic approaches make this an exciting time in ocular oncology.
By Peter K. Kaiser, MD
New Product Applications: At-home OCT Imaging Device Approved
Notal Vision’s Scanly Home OCT device allows clinicians to monitor disease activity in the eyes of patients with neovascular AMD between office visits.
By Karen Appold, contributing writer
Coding Q&A: Billing for Injectable Drugs
Requests for additional documentation from payors are common, so precise chart documentation of the injection procedure is crucial.
By Brandy H. Sperry, COMT, COE, CPC, CPMA
Clinical Trial Update September 2024
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
Supported Content
Ultra-Widefield Image of the Month
A Case for Steered UWF Imaging
By Janelle Fassbender Adeniran, MD
Anti-complement Injections for Geographic Atrophy: A Look at the Patient and Provider Experience in my Clinic
Patient selection, education, and safety are paramount to successful implementation
By Tanuj Banker, MD
Validating Patient Concerns Regarding Geographic Atrophy and Treatment
It is crucial to acknowledge and validate patients' concerns about their visual impairments
By Priya Vakharia, MD
Data on CUO6 from ASRS 2024: The Pill that Could Treat DME
Trials so far show potential compliance and preventive benefits
By Victor Gonzalez, MD, Michael A. Singer, MD